Page last updated: 2024-11-05

zonisamide and Hypoplastic Left Heart Syndrome

zonisamide has been researched along with Hypoplastic Left Heart Syndrome in 1 studies

Zonisamide: A benzisoxazole and sulfonamide derivative that acts as a CALCIUM CHANNEL blocker. It is used primarily as an adjunctive antiepileptic agent for the treatment of PARTIAL SEIZURES, with or without secondary generalization.
zonisamide : A 1,2-benzoxazole compound having a sulfamoylmethyl substituent at the 3-position.

Hypoplastic Left Heart Syndrome: A condition caused by underdevelopment of the whole left half of the heart. It is characterized by hypoplasia of the left cardiac chambers (HEART ATRIUM; HEART VENTRICLE), the AORTA, the AORTIC VALVE, and the MITRAL VALVE. Severe symptoms appear in early infancy when DUCTUS ARTERIOSUS closes.

Research Excerpts

ExcerptRelevanceReference
"Lacosamide decreases seizure burden by modulating sodium channels."1.42Lacosamide-induced atrial tachycardia in a child with hypoplastic left-heart syndrome: the importance of assessing additional proarrhythmic risks. ( Gudausky, TM; Kovach, J; Loomba, RS; Singh, AK, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Loomba, RS1
Singh, AK1
Kovach, J1
Gudausky, TM1

Other Studies

1 other study available for zonisamide and Hypoplastic Left Heart Syndrome

ArticleYear
Lacosamide-induced atrial tachycardia in a child with hypoplastic left-heart syndrome: the importance of assessing additional proarrhythmic risks.
    Cardiology in the young, 2015, Volume: 25, Issue:4

    Topics: Acetamides; Anticonvulsants; Arrhythmias, Cardiac; Child, Preschool; Comorbidity; Humans; Hypoplasti

2015